Include Tramadol associated Hiccups In Patient Information Leaflet: CDSCO Panel
Advertisement
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has issued recommendations stating that CDSCO should request state drugs controllers to direct the manufacturers of the opioid analgesic Tramadol to include Tramadol associated hiccups in the Patient Information Leaflet (PIL) of the marketed products in the country.
This was in line with the recommendations of the signal review panel, which were presented to the committee along with the additional data received from the Pharmacovigilance Programme of India—Indian Pharmacopoeia Commission (PvPI—IPC).
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.